EUROPE CRISPR MARKET 2019-2028

Lifesciences | Diagnostic & Biotechnology

EUROPE CRISPR MARKET 2019-2028

Market By Product, Application And End-user | Forecast 2019-2028

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

An analysis by Triton Market Research has concluded that the European CRISPR market will bloom in terms of revenue at a CAGR of 22.99% in the forthcoming years 2019-2028.



We provide additional customization based on your specific requirements. Request For Customization

The countries evaluated in the Europe CRISPR market are:

           Italy

           The United Kingdom

           Germany

           Russia

           France

           Spain  

           Rest of Europe

Gene-editing in humans is not legal in the United Kingdom. A molecular biologist, Kathy Niakan and her team have been granted permission to utilize CRISPR/Cas9 technology on human embryos only for the purpose of better learning human embryo development. Other than these research scientists, no one else is permitted to use this technique in the country. The committee of HFEA provided the license on the condition that the embryos used in the various experiments must be received from donors. Also, the research team must work on embryos donated by women, who have already undergone the process of IVF (in-vitro fertilization) and having surplus embryos.

The researchers want to study the consequence of different genes in the first week of embryonic development, while the embryo has only 1 to 250 cells approximately. The license also declares that these embryos must be destroyed within 14 days, and are not permitted to be implanted in a woman. Such genetic modification studies are likely to help the researchers in the development of infertility treatment. However, it cannot be considered as a basis of therapy. These developments in the field are likely to boost the CRISPR (Clustered Regularly Interspaced Short Palindrome Repeats) market in the country in the forthcoming period.

Established in 2005, Horizon Discovery Ltd is a UK-based genomics company. It provides products, including genome editing tools, short hairpin ribonucleic acid, reporter kits and support services. It also offers in-vitro and in-vivo assay development in different sectors, like cell growth, apoptosis, signal transduction and metastasis. The company offers its services to diagnostic companies, the pharmaceutical & biotechnological sector and academic research centers. Horizon Discovery has its headquarters in Cambridge, UK and is operating majorly in Latin America, Asia-Pacific, Europe and Africa.

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1.    EUROPE CRISPR MARKET – SUMMARY

2.    INDUSTRY OUTLOOK

2.1. MARKET DEFINITION

2.2. PORTER’S FIVE FORCES MODEL

2.2.1.   THREAT OF NEW ENTRANTS

2.2.2.   THREAT OF SUBSTITUTE PRODUCTS

2.2.3.   BARGAINING POWER OF BUYERS

2.2.4.   BARGAINING POWER OF SUPPLIERS

2.2.5.   COMPETITIVE RIVALRY

2.3. REGULATORY OUTLOOK

2.4. VALUE CHAIN OUTLOOK

2.5. SUPPLY CHAIN OUTLOOK

2.6. TIMELINE OF CRISPR MARKET

2.7. PARENT MARKET OUTLOOK

2.8. KEY INSIGHT

2.9. MARKET ATTRACTIVENESS INDEX

2.10. MARKET DRIVERS

2.10.1. GROWING LIFESTYLE-ORIENTED DISEASES

2.10.2. SURGING PREVALENCE OF GENETIC DISEASES

2.10.3. INCREASING APPLICATION OF DRUGS

2.10.4. RISING AGING POPULATION

2.10.5. INCIDENCE OF GENETIC AILMENTS

2.11.  MARKET RESTRAINTS

2.11.1.  ETHICAL AND SOCIAL ISSUES ASSOCIATED WITH CRISPR TECHNOLOGY

2.11.2.  CHANGING REGULATORY ENVIRONMENT

2.12.  MARKET OPPORTUNITIES

2.12.1.   INCREASED DEMAND FOR CRISPR  

2.12.2.   ADVANCEMENTS IN THE APPLICATIONS OF GENE-BASED THERAPY

2.13.  MARKET CHALLENGES

2.13.1.  ALTERNATIVE TECHNOLOGIES

2.13.2.  LACK OF AWARENESS REGARDING THE TECHNOLOGY

3.    CRISPR MARKET OUTLOOK - BY PRODUCT

3.1. PLASMIDS

3.2. VECTORS

3.3. PROTEINS

3.4. DESIGN TOOLS

3.5. GRNA

3.6. CONTROL KITS

3.7. LIBRARY

3.8. OTHER PRODUCTS

4.    CRISPR MARKET OUTLOOK - BY APPLICATION

4.1. GENOME EDITING/GENETIC ENGINEERING

4.2. GRNA DATABASE/GENE LIBRARY

4.3. CRISPR PLASMID

4.4. HUMAN STEM CELLS

4.5. CELL LINE ENGINEERING

5.    CRISPR MARKET OUTLOOK - BY END-USER

5.1. THERAPEUTICS & DRUG DISCOVERY

5.2. BIOLOGICAL RESEARCH

5.3. AGRICULTURAL BIOTECH

5.4. INDUSTRIAL BIOTECH

6.    CRISPR MARKET – EUROPE

6.1. THE UNITED KINGDOM

6.2. FRANCE

6.3. GERMANY

6.4. SPAIN

6.5. ITALY

6.6. RUSSIA

6.7. REST OF EUROPE

7.    COMPANY PROFILE

7.1. ADDGENE

7.2. APPLIED STEMCELL

7.3. CARIBOU BIOSCIENCES INC

7.4. CELLECTIS

7.5. CRISPR THERAPEUTICS

7.6. DIACARTA

7.7. EDITAS MEDICINE

7.8. GENECOPOEIA INC

7.9. GENEDATA AG

7.10. GENSCRIPT

7.11.  HORIZON DISCOVERY LTD

7.12. INTEGRATED DNA TECHNOLOGIES INC

7.13.  INTELLIA THERAPEUTICS INC

7.14.  LONZA  

7.15.  NEW ENGLAND BIOLABS  

7.16.  ORIGENE TECHNOLOGIES INC

7.17. PRECISION BIOSCIENCES

7.18.  SANGAMO THERAPEUTICS

7.19. SIGMA-ALDRICH (MERCK KGAA)

7.20.  THERMO FISHER SCIENTIFIC INC

7.21.  TRANSPOSAGEN BIO (HERA BIOLABS)

8.    RESEARCH METHODOLOGY & SCOPE

8.1. RESEARCH SCOPE & DELIVERABLES

8.1.1.   OBJECTIVES OF STUDY

8.1.2.   SCOPE OF STUDY

8.2. SOURCES OF DATA

8.2.1.   PRIMARY DATA SOURCES

8.2.2.   SECONDARY DATA SOURCES

8.3. RESEARCH METHODOLOGY

8.3.1.   EVALUATION OF PROPOSED MARKET

8.3.2.   IDENTIFICATION OF DATA SOURCES

8.3.3.   ASSESSMENT OF MARKET DETERMINANTS

8.3.4.   DATA COLLECTION

8.3.5.   DATA VALIDATION & ANALYSIS

List of table

TABLE 1        EUROPE CRISPR MARKET, 2019-2028 ($ MILLION)

TABLE 2        CHIEF CONCERNS RELATED TO GENETIC ENGINEERING

TABLE 3        EUROPE CRISPR MARKET, BY PRODUCT, 2019-2028 ($ MILLION)

TABLE 4        TOOL NAMES AND THEIR PROVIDERS

TABLE 5        EUROPE CRISPR MARKET, BY APPLICATION, 2019-2028 ($ MILLION)

TABLE 6        BARRIERS TO ENTRY IN THE AGRICULTURAL SEED MARKET,

TABLE 7        AGRICULTURE BIOTECH TRAITS INDUSTRY

TABLE 8        EUROPE CRISPR MARKET, BY END-USER, 2019-2028 ($ MILLION)

TABLE 9        EUROPE CRISPR MARKET, BY COUNTRY, 2019-2028 ($ MILLION)

List of Figures

FIGURE 1      EUROPE CRISPR MARKET, 2019-2028 ($ MILLION)

FIGURE 2      VALUE CHAIN ANALYSIS

FIGURE 3      EUROPE CRISPR MARKET, BY PLASMIDS, 2019-2028 ($ MILLION)

FIGURE 4      EUROPE CRISPR MARKET, BY VECTORS, 2019-2028 ($ MILLION)

FIGURE 5      EUROPE CRISPR MARKET, BY PROTEINS, 2019-2028 ($ MILLION)

FIGURE 6      EUROPE CRISPR MARKET, BY DESIGN TOOLS, 2019-2028 ($ MILLION)

FIGURE 7      EUROPE CRISPR MARKET, BY GRNA, 2019-2028 ($ MILLION)

FIGURE 8      EUROPE CRISPR MARKET, BY CONTROL KITS, 2019-2028 ($ MILLION)

FIGURE 9      EUROPE CRISPR MARKET, BY LIBRARY, 2019-2028 ($ MILLION)

FIGURE 10   EUROPE CRISPR MARKET, BY OTHER PRODUCTS, 2019-2028 ($ MILLION)

FIGURE 11   EUROPE CRISPR MARKET, BY GENOME EDITING/GENETIC ENGINEERING, 2019-2028 ($ MILLION)

FIGURE 12   EUROPE CRISPR MARKET, BY GRNA DATABASE/GENE LIBRARY, 2019-2028 ($ MILLION)

FIGURE 13   EUROPE CRISPR MARKET, BY CRISPR PLASMID, 2019-2028 ($ MILLION)

FIGURE 14   EUROPE CRISPR MARKET, BY HUMAN STEM CELLS, 2019-2028 ($ MILLION)

FIGURE 15   EUROPE CRISPR MARKET, BY CELL LINE ENGINEERING, 2019-2028 ($ MILLION)

FIGURE 16   EUROPE CRISPR MARKET, BY THERAPEUTICS AND DRUG DISCOVERY, 2019-2028 ($ MILLION)

FIGURE 17   EUROPE CRISPR MARKET, BY BIOLOGICAL RESEARCH, 2019-2028 ($ MILLION)

FIGURE 18   EUROPE CRISPR MARKET, BY AGRICULTURAL BIOTECH, 2019-2028 ($ MILLION)

FIGURE 19   EUROPE CRISPR MARKET, BY INDUSTRIAL BIOTECH, 2019-2028 ($ MILLION)

FIGURE 20   EUROPE CRISPR MARKET, 2019-2028 ($ MILLION)

FIGURE 21   THE UNITED KINGDOM CRISPR MARKET, 2019-2028 ($ MILLION)

FIGURE 22   FRANCE CRISPR MARKET, 2019-2028 ($ MILLION)

FIGURE 23   GERMANY CRISPR MARKET, 2019-2028 ($ MILLION)

FIGURE 24   SPAIN CRISPR MARKET, 2019-2028 ($ MILLION)

FIGURE 25   ITALY CRISPR MARKET, 2019-2028 ($ MILLION)

FIGURE 26   RUSSIA CRISPR MARKET, 2019-2028 ($ MILLION)

FIGURE 27   REST OF EUROPE CRISPR MARKET, 2019-2028 ($ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;